Brain Damage Hiding in 'Normal' B12 Levels, Scientists Find

Brain Damage Hiding in 'Normal' B12 Levels, Scientists Find

Millions of older adults may have vitamin B12 levels that doctors call perfectly healthy while their brains are quietly deteriorating, according to research from the University of California, San Francisco. The finding suggests that current guidelines for what counts as adequate B12 could be dangerously out of sync with actual brain protection.

Scientists enrolled 231 cognitively healthy people with an average age of 71 and measured not just their total B12 but the biologically active form the body can actually use. Their average blood B12 measured 414.8 pmol/L, well above the U.S. minimum threshold of 148 pmol/L. Yet even within this officially normal range, those with lower active B12 performed worse on thinking tests and showed visible brain damage on MRI scans.

"Lower levels of active B12 were linked to slower thinking, slower visual processing, and more visible injury in the brain's white matter," said Ari J. Green, the study's senior author and a neurologist at UCSF. White matter is the wiring that lets different brain regions communicate. The slower processing speed effect was stronger in older participants, suggesting age makes the brain more vulnerable to inadequate B12.

MRI imaging revealed the most alarming signal: people with lower active B12 had a higher volume of white matter lesions, areas of brain tissue damage that are linked to cognitive decline, dementia, and stroke risk. This was true even though all participants were healthy and had no signs of dementia or mild cognitive impairment.

The research, published in Annals of Neurology in 2025, raises a stark possibility. Someone could visit their doctor, receive a normal B12 result, and leave the office unaware that their brain is already showing early signs of stress and injury.

Green argued the current definition of B12 deficiency may be too crude. "The minimum threshold used to define deficiency may not capture early functional changes in the nervous system," he said. He called for medical guidelines to incorporate functional biomarkers, not just raw B12 numbers, and for early intervention before cognitive decline becomes visible.

Older adults face particular risk because B12 absorption naturally declines with age. Some medications, digestive disorders, and plant-based diets also impair B12 status. Alexandra Beaudry-Richard, a co-first author of the study, noted that low but technically normal B12 "may affect a much larger proportion of the population than we realize." She recommended that doctors consider B12 supplementation in older patients showing neurological symptoms even if their lab results fall within normal limits.

Newer research has tempered the picture somewhat. A 2025 meta-analysis of randomized trials found that B vitamin supplementation, including B12, produced only a very small benefit to overall cognitive function in older adults. That analysis was rated as high certainty, suggesting the effect is real but modest. A separate 2025 study using genetic analysis found no clear evidence that higher total serum B12 protects the general population from psychiatric disorders or cognitive decline, though that study measured total B12 rather than the bioactive form.

These mixed findings suggest a more nuanced message. B12 deficiency is genuinely harmful to the nervous system and should not be dismissed. But simply raising B12 levels for everyone will not produce a dramatic cognitive rescue. The real question is whether current testing methods miss people whose brains are already being harmed despite lab results that look fine.

The UCSF study itself does not prove that low active B12 directly causes cognitive decline, only that it correlates with brain changes. Patients should not start taking supplements on their own. But for doctors treating older patients with subtle problems in memory, thinking speed, or vision, the findings suggest that a normal lab result may tell an incomplete story.

Author Jessica Williams: "This research quietly dismantles the assumption that a normal B12 result means your brain is safe, which is exactly the kind of threshold-shifting finding medicine needs to take seriously."

Comments